These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 21153331)

  • 1. Introductory words about TWEAK/Fn14.
    Burkly LC
    Adv Exp Med Biol; 2011; 691():275-7. PubMed ID: 21153331
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
    Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
    Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
    Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
    Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis.
    Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg JO; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjörnsson B
    Int J Oncol; 2013 Apr; 42(4):1239-48. PubMed ID: 23443741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of transcription factor NF kappa B activation by tumor necrosis factor (TNF)].
    Doszczak MM; Kaszubowska L; Pierzchalski A; Bigda J
    Postepy Biochem; 2002; 48(1):54-65. PubMed ID: 12101525
    [No Abstract]   [Full Text] [Related]  

  • 6. Analyzing the signaling capabilities of soluble and membrane TWEAK.
    Trebing J; Arana JA; Salzmann S; Wajant H
    Methods Mol Biol; 2014; 1155():31-45. PubMed ID: 24788171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
    Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK signals through JAK-STAT to induce tumor cell apoptosis.
    Chapman MS; Wu L; Amatucci A; Ho SN; Michaelson JS
    Cytokine; 2013 Jan; 61(1):210-7. PubMed ID: 23107828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
    Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis.
    Morosetti R; Gliubizzi C; Sancricca C; Broccolini A; Gidaro T; Lucchini M; Mirabella M
    Am J Pathol; 2012 Apr; 180(4):1603-13. PubMed ID: 22314077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
    Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J
    Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
    Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TWEAK/Fn14 signaling mediates gastric cancer cell resistance to 5-fluorouracil via NF-κB activation.
    Kwon OH; Kim JH; Kim SY; Kim YS
    Int J Oncol; 2014 Feb; 44(2):583-90. PubMed ID: 24337061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.
    Kawashima R; Kawamura YI; Oshio T; Son A; Yamazaki M; Hagiwara T; Okada T; Inagaki-Ohara K; Wu P; Szak S; Kawamura YJ; Konishi F; Miyake O; Yano H; Saito Y; Burkly LC; Dohi T
    Gastroenterology; 2011 Dec; 141(6):2119-2129.e8. PubMed ID: 21893119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.
    Izquierdo MC; Sanz AB; Mezzano S; Blanco J; Carrasco S; Sanchez-Niño MD; Benito-Martín A; Ruiz-Ortega M; Egido J; Ortiz A
    Kidney Int; 2012 Jun; 81(11):1098-107. PubMed ID: 22278019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation.
    Brown SA; Richards CM; Hanscom HN; Feng SL; Winkles JA
    Biochem J; 2003 Apr; 371(Pt 2):395-403. PubMed ID: 12529173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWEAK/Fn14 axis: the current paradigm of tissue injury-inducible function in the midst of complexities.
    Burkly LC
    Semin Immunol; 2014 Jun; 26(3):229-36. PubMed ID: 24636536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Fn14 in acute alcoholic steatohepatitis in mice.
    Karaca G; Xie G; Moylan C; Swiderska-Syn M; Guy CD; Krüger L; Machado MV; Choi SS; Michelotti GA; Burkly LC; Diehl AM
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G325-34. PubMed ID: 25524063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK regulates proliferation and differentiation of adult neural progenitor cells.
    Schölzke MN; Röttinger A; Murikinati S; Gehrig N; Leib C; Schwaninger M
    Mol Cell Neurosci; 2011 Jan; 46(1):325-32. PubMed ID: 21040786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathway.
    Roos C; Wicovsky A; Müller N; Salzmann S; Rosenthal T; Kalthoff H; Trauzold A; Seher A; Henkler F; Kneitz C; Wajant H
    J Immunol; 2010 Aug; 185(3):1593-605. PubMed ID: 20610643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.